182 related articles for article (PubMed ID: 26836031)
1. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.
Skowronski DM; Sabaiduc S; Chambers C; Eshaghi A; Gubbay JB; Krajden M; Drews SJ; Martineau C; De Serres G; Dickinson JA; Winter AL; Bastien N; Li Y
Euro Surveill; 2016; 21(3):30112. PubMed ID: 26836031
[TBL] [Abstract][Full Text] [Related]
2. Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons.
Kawakami C; Yamayoshi S; Akimoto M; Nakamura K; Miura H; Fujisaki S; Pattinson DJ; Shimizu K; Ozawa H; Momoki T; Saikusa M; Yasuhara A; Usuku S; Okubo I; Toyozawa T; Sugita S; Smith DJ; Watanabe S; Kawaoka Y
Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755292
[TBL] [Abstract][Full Text] [Related]
3. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
[TBL] [Abstract][Full Text] [Related]
4. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.
Fang Q; Gao Y; Chen M; Guo X; Yang X; Yang X; Wei L
Infect Genet Evol; 2014 Aug; 26():228-40. PubMed ID: 24911284
[TBL] [Abstract][Full Text] [Related]
6. Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.
Korsun N; Angelova S; Trifonova I; Tzotcheva I; Mileva S; Voleva S; Georgieva I; Perenovska P
J Med Microbiol; 2018 Feb; 67(2):228-239. PubMed ID: 29297852
[TBL] [Abstract][Full Text] [Related]
7. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
[TBL] [Abstract][Full Text] [Related]
9. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
[TBL] [Abstract][Full Text] [Related]
10. An epidemic surge of influenza A(H3N2) virus at the end of the 2016-2017 season in Taiwan with an increased viral genetic heterogeneity.
Yang JR; Hsu SZ; Kuo CY; Huang HY; Huang TY; Wang HC; Liu MT
J Clin Virol; 2018; 99-100():15-21. PubMed ID: 29278832
[TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.
Eshaghi A; Duvvuri VR; Li A; Patel SN; Bastien N; Li Y; Low DE; Gubbay JB
Influenza Other Respir Viruses; 2014 Mar; 8(2):250-7. PubMed ID: 24313991
[TBL] [Abstract][Full Text] [Related]
12. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
[TBL] [Abstract][Full Text] [Related]
13. Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.
Stucker KM; Schobel SA; Olsen RJ; Hodges HL; Lin X; Halpin RA; Fedorova N; Stockwell TB; Tovchigrechko A; Das SR; Wentworth DE; Musser JM
Euro Surveill; 2015 May; 20(18):. PubMed ID: 25990233
[TBL] [Abstract][Full Text] [Related]
14. Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017.
Harvala H; Frampton D; Grant P; Raffle J; Ferns RB; Kozlakidis Z; Kellam P; Pillay D; Hayward A; Nastouli E;
Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251889
[TBL] [Abstract][Full Text] [Related]
15. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
[TBL] [Abstract][Full Text] [Related]
16. Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?
Kossyvakis A; Pogka V; Melidou A; Moutousi A; Gioula G; Kalliaropoulos A; Exindari M; Emmanouil M; Horefti E; Spala G; Meijer A; Malisiovas N; Mentis AF
J Clin Microbiol; 2015 May; 53(5):1493-9. PubMed ID: 25694524
[TBL] [Abstract][Full Text] [Related]
17. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
18. [Virological characterization of influenza A(H3N2) virus in Mainland China during 2011-2012].
Huang WJ; Cheng YH; Li XY; Zhao X; Guo JF; Wang Z; Tan MJ; Li M; Sui HT; Wei HJ; Chen YY; Xiao N; Lan Y; Wang DY; Shu YL
Bing Du Xue Bao; 2013 May; 29(3):258-64. PubMed ID: 23905468
[TBL] [Abstract][Full Text] [Related]
19. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
[TBL] [Abstract][Full Text] [Related]
20. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
